Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer.
Kyu KimYong Joon LeeTae-Hoon KimJae Sun UhmHui Nam PakMoon-Hyoung LeeBoyoung JoungPublished in: Korean circulation journal (2018)
In AF patients with newly diagnosed cancer, NOACs showed lower incidences of ischemic stroke/SE, major bleeding, and all-cause death than warfarin, especially within 1 year after cancer diagnosis.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- newly diagnosed
- papillary thyroid
- catheter ablation
- left atrial
- squamous cell
- direct oral anticoagulants
- left atrial appendage
- heart failure
- percutaneous coronary intervention
- squamous cell carcinoma
- lymph node metastasis
- coronary artery disease
- childhood cancer
- venous thromboembolism
- young adults